Search Results - "Lansen, J"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Effectiveness of anthracycline against experimental prion disease in Syrian hamsters by Tagliavini, F. (Istituto Nazionale Neurologico Carlo Besta, Milano, Italy.), McArthur, R.A, Canciani, B, Giaccone, G, Porro, M, Bugiani, M, Lievens, P.M.J, Bugiani, O, Peri, E, Dall'Ara, P

    “…Prion diseases are transmissible neurodegenerative conditions characterized by the accumulation of protease-resistant forms of the prion protein (PrP), termed…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator "in vitro" and in a perfused rabbit heart model by Molinari, A, Giorgetti, C, Lansen, J, Vaghi, F, Orsini, G, Faioni, E M, Mannucci, P M

    Published in Thrombosis and haemostasis (1992)
    “…Thrombin cleaves single-chain urokinase-type plasminogen activator (scu-PA) to a two-chain derivative (tcu-PA) fibrinolytically inactive. This reaction was…”
    Get more information
    Journal Article
  5. 5

    Inhibition of vascular smooth muscle cell proliferation in culture by pentosan polysulphate and related compounds by Paul, R, Herbert, J M, Maffrand, J P, Lansen, J, Modat, G, Pereillo, J M, Gordon, J L

    Published in Thrombosis research (15-06-1987)
    “…Pentosan polysulphate (PPS; SP 54; Hemoclar), a highly sulphated semi-synthetic polysaccharide of MW 4.7 kD, was tested in vitro as an inhibitor of rabbit…”
    Get more information
    Journal Article
  6. 6

    Extreme wave event along the Guyana coastline in October 2005 by van Ledden, Mathijs, Vaughn, Geoffrey, Lansen, Joost, Wiersma, Frank, Amsterdam, Mewburn

    Published in Continental shelf research (15-01-2009)
    “…The objective of the research is to analyze in detail the causes and consequences of the unusual event at the coast of Guyana (South America) during October…”
    Get full text
    Journal Article
  7. 7

    Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro by Longo, Monica, Zanoncelli, Sara, Manera, Debora, Brughera, Marco, Colombo, Paolo, Lansen, Jacqueline, Mazué, Guy, Gomes, Melba, Taylor, Walter R.J., Olliaro, Piero

    “…Artemisinin derivatives are not currently recommended for use during the first trimester of pregnancy because they cause embryo death and some abnormalities in…”
    Get full text
    Journal Article
  8. 8

    Psycho-educative group psychotherapy for Jewish child-survivors of the Holocaust and non-Jewish child-survivors of Japanese concentration camps by Lansen, J, Cels, J P

    “…The authors describe the application of a form of group psychotherapy for middle aged patients with a past history of being child-survivors of the Second World…”
    Get more information
    Journal Article
  9. 9

    Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration by Sié, P, Lansen, J, Lacheretz, F, Verschuere, B, Boneu, B

    Published in Thrombosis and haemostasis (15-12-1986)
    “…Heparin and pentosan polysulfate (PPS) interact in plasma with antithrombin III (AT III) and Heparin cofactor II (HC II) respectively. To assess the influence…”
    Get more information
    Journal Article
  10. 10

    "Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties by Naggi, A, Torri, G, Casu, B, Pangrazzi, J, Abbadini, M, Zametta, M, Donati, M B, Lansen, J, Maffrand, J P

    Published in Biochemical pharmacology (15-06-1987)
    “…A new type of low-molecular-weight heparin (ss-LMW-H) was prepared (by controlled depolymerization and concurrent sulfation of heparin with a mixture of…”
    Get more information
    Journal Article
  11. 11

    Efficient renaturation and fibrinolytic properties of prourokinase and a deletion mutant expressed in Escherichia coli as inclusion bodies by ORSINI, Gaetano, BRANDAZZA, Anna, SARMIENTOS, Paolo, MOLINARI, Antonio, LANSEN, Jacqueline, CAUET, Gilles

    Published in European journal of biochemistry (14-02-1991)
    “…Prourokinase is a plasminogen activator of 411 amino acids which displays a clot‐lysis activity through a fibrin‐dependent mechanism, and which seems to be a…”
    Get full text
    Journal Article
  12. 12

    Tolerance and biological activity of pentosan polysulfate after intramuscular or subcutaneous administration for ten days in human volunteers by Sié, P, Albarede, J L, Robert, M, Bouloux, C, Lansen, J, Chigot, C, Correll, S, Thouvenot, J P, Boneu, B

    Published in Thrombosis and haemostasis (1986)
    “…This study reports on the tolerance and the pharmacological activity of pentosan polysulfate (PPS) administered to healthy volunteers for 10 days. Three groups…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients by Roncucci, R, De Hertogh, R, Dormandy, J A, Doumont, J, Gurewich, V, Lambelin, G, Lansen, J, Rottiers, R, Souridis, E, Van Stalle, F, Versee, L

    Published in Arzneimittel-Forschung (1979)
    “…1-(4-Isopropylthiophenyl)-2-n-octylaminopropanol (suloctidil, Sulocton), a drug introduced into clinical practice for the treatment of cerebral and peripheral…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Prolonged Half‐Life in the Circulation of a Chemical Conjugate Between a Pro‐Urokinase Derivative and Human Serum Albumin by Breton, Jérôme, Pezzi, Nieves, Molinari, Antonio, Bonomini, Luisella, Lansen, Jacqueline, Buitrago, Gonzalo Gonzalez, Prieto, Ignacio

    Published in European journal of biochemistry (01-08-1995)
    “…Pro‐urokinase is a natural plasminogen activator that displays a clot‐lysis activity through a fibrin‐dependent mechanism. It seems to be a promising agent for…”
    Get full text
    Journal Article
  19. 19
  20. 20